Selected article for: "blood serum and different assay"

Author: Meng, Fandan; Ren, Yudong; Suo, Siqingaowa; Sun, Xuejiao; Li, Xunliang; Li, Pengchong; Yang, Wei; Li, Guangxing; Li, Lu; Schwegmann-Wessels, Christel; Herrler, Georg; Ren, Xiaofeng
Title: Evaluation on the Efficacy and Immunogenicity of Recombinant DNA Plasmids Expressing Spike Genes from Porcine Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus
  • Document date: 2013_3_19
  • ID: 081o2zmd_44
    Snippet: T cells are important effector cells of immune responses. Their activation causes the secretion of cytokines that advance cellular and humoral immune responses and mediate CTL activity. As such, monitoring CTL activity provides a good readout for immune stimulation. In this study, spleen and blood-derived lymphocytes from immunized mice clearly showed that immunization with pIRES-(TGEV-S1-PEDV-S1) and pIRES-(TGEV-S1-PEDV-S) significantly induced .....
    Document: T cells are important effector cells of immune responses. Their activation causes the secretion of cytokines that advance cellular and humoral immune responses and mediate CTL activity. As such, monitoring CTL activity provides a good readout for immune stimulation. In this study, spleen and blood-derived lymphocytes from immunized mice clearly showed that immunization with pIRES-(TGEV-S1-PEDV-S1) and pIRES-(TGEV-S1-PEDV-S) significantly induced T cell proliferation. When stimulated with purified recombinant PEDV-S1 protein, there was Figure 8 . Levels of neutralizing antibodies in mice treated with pIRES-(TGEV-S1-PEDV-S1) and pIRES-(TGEV-S1-PEDV-S). Anti-PEDV and anti-TGEV neutralizing antibodies in immunized mice were detected by plaque reduction assay with different serum dilutions from blood samples taken at 28 days after the injection of the plasmid DNAs. doi:10.1371/journal.pone.0057468.g008 higher T lymphocyte proliferation in the pIRES-(TGEV-S1-PEDV-S) group than in the pIRES-(TGEV-S1-PEDV-S1) group.

    Search related documents:
    Co phrase search for related documents
    • anti PEDV and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • anti PEDV and lymphocyte proliferation: 1, 2
    • anti PEDV and PEDV s1: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • anti PEDV and PEDV s1 protein: 1, 2, 3, 4, 5, 6
    • anti PEDV and plasmid dna: 1, 2
    • anti PEDV and recombinant PEDV s1 protein: 1, 2, 3
    • anti PEDV and S1 group: 1
    • anti PEDV and S1 immunization: 1
    • anti PEDV and serum dilution: 1
    • anti tgev and humoral cellular immune response: 1
    • anti tgev and immune response: 1, 2
    • anti tgev and PEDV s1: 1, 2
    • anti tgev and PEDV s1 protein: 1
    • anti tgev and plasmid dna: 1
    • anti tgev and recombinant PEDV s1 protein: 1
    • anti tgev and S1 group: 1
    • anti tgev and serum dilution: 1